Improving Food Pleasure and Intake of Oncology Patients Receiving Chemotherapy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-07-31

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The global cancer burden is estimated to have risen to 18.1 million new cases in 2018 (WHO), with a trend of ongoing growth. This very frequent illness exerts tremendous physical, emotional and financial strain on individuals, families, communities and health systems.

Malnutrition (under- or over-nutrition) is highly prevalent in cancer patients receiving chemotherapy and is an important predictor of morbidity, mortality, treatment response and toxicity. Alterations in taste and smell are frequently reported as side effect of chemotherapy and may contribute strongly to malnutrition and to a worsen quality of life and wellbeing social, emotional, and role functioning. There are evidences that chemotherapy influences food liking and appetite with implications for food behaviours, including food enjoyment, food preference and dietary intake. A linkage between alterations in taste and /or smell and food behaviours has been reported by some studies but not all, suggesting that there is a need for more research using common standardised methodologies and larger sample size to gain a further insight into this topic.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact on the Nutritional State and the Quality of Life

NCT01687335

Cancer

COMPLETED

Nutrition Health Literacy of Cancer Patients and Their Support Networks.

NCT03978312

Cancer Oncologic Disorders Haematological Malignancy +1 more

TERMINATED

The Nutritional Status of Chemo-radiotherapy Patients

NCT01937273

Malnutrition Cancer

COMPLETED

CAncer, NUtrition and Taste 2

NCT05027490

Breast Cancer Gynecologic Cancer Bronchial Cancer +1 more

COMPLETED NA

Somesthesia in Cancer Patients: Variability and Influence on Eating Experience

NCT06803381

Digestive Cancers Breast Cancer Gynecologic Cancer +4 more

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colon Cancer Breast Cancer Chemotherapeutic Toxicity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patients with colon cancer

Chemotherapy

Intervention Type DRUG

standard adjuvat chemotherapy for reast and colo cancer

patients with breast cancer

Chemotherapy

Intervention Type DRUG

standard adjuvat chemotherapy for reast and colo cancer

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Chemotherapy

standard adjuvat chemotherapy for reast and colo cancer

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* pathological diagnosis of colorectal or breast cacer
* indication to adjuvant chemotherapy for colon cancer according local guide lines
* indication to (neo)-adjuvant chemotherapy for reast cancer according local guide lines
* possiility to sign an informed consent